BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26874201)

  • 21. Two subpopulations of thrombin-activated platelets differ in their binding of the components of the intrinsic factor X-activating complex.
    Panteleev MA; Ananyeva NM; Greco NJ; Ataullakhanov FI; Saenko EL
    J Thromb Haemost; 2005 Nov; 3(11):2545-53. PubMed ID: 16241952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of a homozygous Gly11Val mutation in the Gla domain of coagulation factor X.
    Chafa O; Tagzirt M; Tapon-Bretaudière J; Reghis A; Fischer AM; LeBonniec BF
    Thromb Res; 2009 May; 124(1):144-8. PubMed ID: 19135706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Partial rescue of naturally occurring active site factor X variants through decreased inhibition by tissue factor pathway inhibitor and antithrombin.
    Ahnström J; Gierula M; Temenu J; Laffan MA; Lane DA
    J Thromb Haemost; 2020 Jan; 18(1):136-150. PubMed ID: 31466141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Binding of plasminogen and tissue plasminogen activator to plasmin-modulated factor X and factor Xa.
    Grundy JE; Lavigne N; Hirama T; MacKenzie CR; Pryzdial EL
    Biochemistry; 2001 May; 40(21):6293-302. PubMed ID: 11371191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Properties of the factor Xa binding site on human platelets.
    Miletich JP; Jackson CM; Majerus PW
    J Biol Chem; 1978 Oct; 253(19):6908-16. PubMed ID: 690132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The assembly of the factor X-activating complex on activated human platelets.
    Ahmad SS; London FS; Walsh PN
    J Thromb Haemost; 2003 Jan; 1(1):48-59. PubMed ID: 12871539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of storage-induced platelet microparticles on the initiation and propagation phase of blood coagulation.
    Keuren JF; Magdeleyns EJ; Govers-Riemslag JW; Lindhout T; Curvers J
    Br J Haematol; 2006 Aug; 134(3):307-13. PubMed ID: 16848773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet membrane-mediated coagulation protease complex assembly.
    Ahmad SS; Walsh PN
    Trends Cardiovasc Med; 1994; 4(6):271-8. PubMed ID: 21244878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A binding site expressed on the surface of activated human platelets is shared by factor X and prothrombin.
    Scandura JM; Ahmad SS; Walsh PN
    Biochemistry; 1996 Jul; 35(27):8890-902. PubMed ID: 8688425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Role of phospholipids in hemostasis].
    Sletnes KE
    Tidsskr Nor Laegeforen; 1993 Aug; 113(18):2238-41. PubMed ID: 8362386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Binding sites for blood coagulation factor Xa and protein S involving residues 493-506 in factor Va.
    Heeb MJ; Kojima Y; Hackeng TM; Griffin JH
    Protein Sci; 1996 Sep; 5(9):1883-9. PubMed ID: 8880912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet heterogeneity: variation in coagulation complexes on platelet subpopulations.
    Kempton CL; Hoffman M; Roberts HR; Monroe DM
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):861-6. PubMed ID: 15653564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A flow cytometric method for determining the binding of coagulation factor X to monocytes in whole human blood.
    Le Guyader A; Davis-Gorman G; Copeland JG; McDonagh PF
    J Immunol Methods; 2004 Sep; 292(1-2):207-15. PubMed ID: 15350525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences between human and rabbit coagulation factor X-implications for in vivo models of thrombosis.
    Edwards ST; Betz A; James HL; Thompson E; Yonkovich SJ; Sinha U
    Thromb Res; 2002 Apr; 106(1):71-9. PubMed ID: 12165292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of procoagulant binding sites on the platelet surface.
    Bevers EM; Rosing J; Zwaal RF
    Adv Exp Med Biol; 1985; 192():359-71. PubMed ID: 3914834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of activated human platelets in prothrombin and factor X activation.
    Rosing J; van Rijn JL; Bevers EM; van Dieijen G; Comfurius P; Zwaal RF
    Blood; 1985 Feb; 65(2):319-32. PubMed ID: 3967085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasmin converts factor X from coagulation zymogen to fibrinolysis cofactor.
    Pryzdial EL; Lavigne N; Dupuis N; Kessler GE
    J Biol Chem; 1999 Mar; 274(13):8500-5. PubMed ID: 10085082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet membrane involvement in blood coagulation.
    Hemker HC; van Rijn JL; Rosing J; van Dieijen G; Bevers EM; Zwaal RF
    Blood Cells; 1983; 9(2):303-17. PubMed ID: 6661560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ixolaris binding to factor X reveals a precursor state of factor Xa heparin-binding exosite.
    Monteiro RQ; Rezaie AR; Bae JS; Calvo E; Andersen JF; Francischetti IM
    Protein Sci; 2008 Jan; 17(1):146-53. PubMed ID: 18042685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extracellular vesicles from activated platelets possess a phospholipid-rich biomolecular profile and enhance prothrombinase activity.
    Guerreiro EM; Kruglik SG; Swamy S; Latysheva N; Østerud B; Guigner JM; Sureau F; Bonneau S; Kuzmin AN; Prasad PN; Hansen JB; Hellesø OG; Snir O
    J Thromb Haemost; 2024 May; 22(5):1463-1474. PubMed ID: 38266680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.